Neil Nachshen
Neil's portfolio has steadily evolved and is now focused on EPO oppositions and appeals, the provision of validity and infringement opinions, due diligence and litigation support, all in the field of pharmaceuticals. He still maintains expertise in advising small pharmaceutical companies in portfolio development and strategy, in particular in conjunction with due diligence for funding and stock market flotations. Neil has been successful in many oppositions and appeals in the pharmaceutical area – mainly acting for Teva Pharmaceuticals Ltd. on patents concerning the second medical use of approved drugs, formulations, polymorphs and synthetic processes. These cases have often been linked to litigation in EU member states. Neil is qualified as a patent agent litigator. · D Young & Co LLP
About
Partner at D Young & Co focused on EPO oppositions and appeals, validity and infringement opinions, due diligence and litigation support in the pharmaceutical field. Qualified as a chartered and European patent attorney and as a patent agent litigator, with experience advising small pharmaceutical companies on portfolio strategy and acting for clients such as Teva.
Practice areas
Office
Expertise
Education
- Kings College, University of London (BSc in Pharmacology)
- Queen Mary College, University of London (Certificate in Intellectual Property Law)
Admissions
- Chartered Patent Attorney (1996)
- European Patent Attorney (1996)
- Patent Agent Litigator